Aridis Pharmaceuticals

+$0.01 (+0.85%) As of 3:08 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARDS and other ETFs, options, and stocks.

About ARDS

Aridis Pharmaceuticals, Inc. engages in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections. Its products include AR-301, AR-101, AR-501, AR-712, AR-701, AR-401, AR-105 and AR-201.

CEO
Vu L. Truong
Employees
34
Headquarters
Los Gatos, California
Founded
2003

ARDS Key Statistics

Market cap
20.89M
Price-Earnings ratio
—
Dividend yield
—
Average volume
73.58K
High today
$1.19
Low today
$1.16
Open price
$1.17
Volume
4.98K
52 Week high
$7.72
52 Week low
$0.88

ARDS Earnings

-$1.94
-$1.29
-$0.65
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure